Shares of Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) hit a new 52-week high on Thursday . The company traded as high as $47.00 and last traded at $47.00, with a volume of 81027 shares. The stock had previously closed at $46.28.
Wall Street Analysts Forecast Growth
Separately, BNP Paribas cut Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, December 2nd.
View Our Latest Analysis on Sandoz Group
Sandoz Group Stock Up 1.6 %
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
- Five stocks we like better than Sandoz Group
- What Are Dividend Contenders? Investing in Dividend Contenders
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- How to Use the MarketBeat Stock Screener
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Are Penny Stocks a Good Fit for Your Portfolio?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
